Skip to main content
×
Home
    • Aa
    • Aa
  • Access
  • Cited by 86
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Chen, Chin-Chu Li, I-Chen Lin, Ting-Wei Chang, Hsiao-Ling Lin, Wen-Hsin and Shen, You-Cheng 2016. Efficacy and safety of oral Antrodia cinnamomea mycelium in mildly hypertensive adults: A randomized controlled pilot clinical study. European Journal of Integrative Medicine,


    Lafarga, Tomas and Hayes, Maria 2016. Bioactive protein hydrolysates in the functional food ingredient industry: Overcoming current challenges. Food Reviews International, p. 1.


    Lafarga, Tomas Gallagher, Eimear Aluko, Rotimi E. Auty, Mark A. E. and Hayes, Maria 2016. Addition of an Enzymatic Hydrolysate of Bovine Globulins to Bread and Determination of Hypotensive Effects in Spontaneously Hypertensive Rats. Journal of Agricultural and Food Chemistry, Vol. 64, Issue. 8, p. 1741.


    Asemi, Zatollah Bahmani, Sahar Shakeri, Hossein Jamal, Atefeh and Faraji, Ali-Mohammad 2015. Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes. International Journal of Diabetes in Developing Countries, Vol. 35, Issue. 2, p. 90.


    Fekete, Ágnes Givens, D. and Lovegrove, Julie 2015. Casein-Derived Lactotripeptides Reduce Systolic and Diastolic Blood Pressure in a Meta-Analysis of Randomised Clinical Trials. Nutrients, Vol. 7, Issue. 1, p. 659.


    Hill, D. R. and Newburg, D. S. 2015. Clinical applications of bioactive milk components. Nutrition Reviews, Vol. 73, Issue. 7, p. 463.


    Watanabe, Machiko Kurihara, Junichi Suzuki, Shigeto Nagashima, Kazuki Hosono, Hiroyuki and Itagaki, Fumio 2015. The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril. Journal of Pharmaceutical Health Care and Sciences, Vol. 1, Issue. 1,


    Alhaj, O.A. and Kanekanian, A. 2014. Milk and Dairy Products as Functional Foods.


    Baba, A. S. Najarian, A. Shori, A. B. Lit, K. W. and Keng, G. A. 2014. Viability of Lactic Acid Bacteria, Antioxidant Activity and In Vitro Inhibition of Angiotensin-I-Converting Enzyme of Lycium barbarum Yogurt. Arabian Journal for Science and Engineering, Vol. 39, Issue. 7, p. 5355.


    Hai Bang, Tran Suhara, Hiroto Doi, Katsumi Ishikawa, Hiroya Fukami, Katsuya Parajuli, Gopal Prasad Katakura, Yoshinori Yamashita, Shuntaro Watanabe, Kazuo Adhikari, Mahesh Kumar Manandhar, Hira Kaji Kondo, Ryuichiro and Shimizu, Kuniyoshi 2014. Wild Mushrooms in Nepal: Some Potential Candidates as Antioxidant and ACE-Inhibition Sources. Evidence-Based Complementary and Alternative Medicine, Vol. 2014, p. 1.


    Hai-Bang, Tran and Shimizu, Kuniyoshi 2014. Potent angiotensin-converting enzyme inhibitory tripeptides identified by a computer-based approach. Journal of Molecular Graphics and Modelling, Vol. 53, p. 206.


    Beermann, Christopher and Hartung, Julia 2013. Physiological properties of milk ingredients released by fermentation. Food Funct., Vol. 4, Issue. 2, p. 185.


    Bejjani, Satyanarayana and Wu, Jianping 2013. Transport of IRW, an Ovotransferrin-Derived Antihypertensive Peptide, in Human Intestinal Epithelial Caco-2 Cells. Journal of Agricultural and Food Chemistry, Vol. 61, Issue. 7, p. 1487.


    Goudarzi, Mostafa and Madadlou, Ashkan 2013. Influence of whey protein and its hydrolysate on prehypertension and postprandial hyperglycaemia in adult men. International Dairy Journal, Vol. 33, Issue. 1, p. 62.


    McCarthy, A.L. O’Connor, T.P. and O’Brien, N.M. 2013. Handbook of cheese in health.


    McCarthy, A.L. O’Connor, T.P. and O’Brien, N.M. 2013. Handbook of cheese in health.


    Qin, L.-Q. Xu, J.-Y. Dong, J.-Y. Zhao, Y. van Bladeren, P. and Zhang, W. 2013. Lactotripeptides intake and blood pressure management: A meta-analysis of randomised controlled clinical trials. Nutrition, Metabolism and Cardiovascular Diseases, Vol. 23, Issue. 5, p. 395.


    Turpeinen, Anu M. Järvenpää, Salme Kautiainen, Hannu Korpela, Riitta and Vapaatalo, Heikki 2013. Antihypertensive effects of bioactive tripeptides—a random effects meta-analysis. Annals of Medicine, Vol. 45, Issue. 1, p. 51.


    Wakai, Taketo Shinoda, Tadashi Uchida, Naoto Hattori, Masahira Nakamura, Yasunori Beresford, Tom Ross, R. Paul and Yamamoto, Naoyuki 2013. Comparative analysis of proteolytic enzymes need for processing of antihypertensive peptides between Lactobacillus helveticus CM4 and DPC4571. Journal of Bioscience and Bioengineering, Vol. 115, Issue. 3, p. 246.


    Zhao, Cindy J. Hu, Ying Schieber, Andreas and Gänzle, Michael 2013. Fate of ACE-inhibitory peptides during the bread-making process: Quantification of peptides in sourdough, bread crumb, steamed bread and soda crackers. Journal of Cereal Science, Vol. 57, Issue. 3, p. 514.


    ×

Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension

Abstract

We describe a clinical trial to study the efficacy of a casein hydrolysate, prepared using an Aspergillus oryzae protease, containing the major angiotensin-I-converting enzyme inhibitory peptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) in a single-blind, placebo-controlled study. A total of 131 volunteers with high-normal blood pressure and mild hypertension were randomly divided into four groups (n 32 or 33 in each group). Each volunteer was given two tablets containing four different dosages of VPP and IPP (VPP+IPP: 0, 1·8, 2·5 and 3·6 mg), daily for 6 weeks. A significant decrease in systolic blood pressure was observed at 6 weeks in the active group receiving 1·8 mg (P<0·01) VPP and IPP; in the active groups receiving either 2·5 mg or 3·6 mg, systolic blood pressure was decreased at both 3 weeks (P<0·05 and P<0·05) and 6 weeks (P<0·001 and P<0·0001) compared with systolic blood pressure measured before treatment. Changes in the systolic blood pressure after 6 weeks of treatment in the four groups were −1·7, −6·3, −6·7 and −10·1 mmHg, and these effects were dose dependent. In addition, a significant difference in systolic blood pressure between the placebo group and the VPP and IPP group receiving 3·6 mg was observed (P<0·001) by two-way ANOVA. The antihypertensive effect was greater in mildly hypertensive subjects (n 20 or 21 in each group) than in any of the other subjects. No significant change of diastolic blood pressure was observed for all the test groups, and no differences in diastolic blood pressure in the test sample groups compared with the placebo group were observed during the test period.

    • Send article to Kindle

      To send this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension
      Your Kindle email address
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr Naoyuki Yamamoto, fax +81 042 769 7810, email naoyuki.yamamoto@calpis.co.jp
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

PR Conlin , D Chow , ER Miller 3rd LP Svetkey , PH Lin , DW Harsha , TJ Moore , FM Sacks & LJ Appel (2000) The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertension 13, 949955.

RK Ferguson , PH Vlasses , JR Koplin , A Shirinian , JF Burke Jr & JC Alexande (1980) Captopril in severe treatment-resistant hypertension. Am Heart J 99, 579585.

T Kawasaki , E Seki , K Osajima , M Yoshida , K Asada , T Matsui & Y Osajima (2000) Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14, 519523.

M Maeno , N Yamamoto & T Takano (1996) Identification of an antihypertensive peptide from casein hydrolyzate by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 79, 13161321.

S Maruyama , K Nakagomi , N Tomizuka & H Suzuki (1985) Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agric Biol Chem 49, 14051409.

N Matsumura , M Fujii , Y Takeda , K Sugita & T Shimizu (1993) Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 57, 695697.

H Meisel & W Bockelmann (1999) Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leewenhoek 76, 207215.

S Miyoshi , H Ishikawa , T Kaneko , F Fukui , H Tanaka & S Maruyama (1991) Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric Biol Chem 55, 13131318.

S Mizuno , S Nishimura , K Matsuura , T Gotou & N Yamamoto (2004) Release of short and proline rich antihypertensive peptides from casein hydrolyzate with an Aspergillus oryzae protease. J Dairy Sci 87, 31833188.

TJ Moore , WM Vollmer , LJ Appel , (1999) Effect of dietary patters on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial: DASH collaborative research group. Hypertension 34, 472477.

Y Nakamura , O Masuda & T Takano (1996) Decrease of tissue angiotensinI-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotech Biochem 60, 488489.

Y Nakamura , N Yamamoto , K Sakai , A Okubo , S Yamazaki & T Takano (1995a) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78, 777783.

J Staessen (1981) The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin-angiotensin-aldosterone system. Clin Sci 61, 441444.

M Stornello , G Di Rao , M Iachello , (1983) Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension 5, 154156.

LP Svetkey , TJ Moore , DG Simons-Morton , (2001) DASH collaborative research group Angiotensinogen genotype and blood pressure response in the dietary approaches to top hypertension (DASH) study. J Hypertens 19, 19491956.

T Takano (1998) Milk derived peptides and hypertension reduction. Int Dairy J 8, 375381.

N Yamamoto , A Akino & T Takano (1994) Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 58, 776778.

N Yamamoto , M Ejiri & S Mizuno (2003) Biogenic peptides and their potential use. Curr Pharmaceut Design 9, 13451355.

N Yamamoto & T Takano (1999) Antihypertensive peptides derived from milk proteins. Nahrung 43, 159164.

N Yamamoto , M Maeno & T Takano (1999) Purification of the antihypertensive peptide from yogurt-like product. J Dairy Sci 82, 13881393.

K Yokoyama , H Chiba & M Yoshikawa (1992) Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci Biotechnol Biochem 56, 15411545.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: